From the earliest stage of life, we examine your genetic map with the latest next-generation sequencing (NGS) and molecular analysis technologies.
- PGT (Preimplantation Genetic Diagnosis / Screening): Analyses performed on embryos before transfer during IVF.
- PGT-A: Detection of trisomies (Down syndrome, etc.) and numerical chromosomal disorders.
- PGT-M: Detection of familial single-gene diseases (SMA, cystic fibrosis, thalassemia, etc.) at the embryo stage.
- PGT-SR: Analysis of structural chromosomal rearrangements (translocations, etc.) in the mother or father.
- NIPT (Non-Invasive Prenatal Test): Screening for Down syndrome and other chromosomal disorders with over 99% accuracy and no risk to mother or baby, through analysis of cell-free fetal DNA (cfDNA) in the mother's blood from the 10th week of pregnancy.
- Advanced Prenatal Diagnosis & Molecular Cytogenetics: Definitive diagnostic solutions with karyotype analysis and cytogenomic microarray (array-CGH) on amniocentesis and CVS samples, and whole exome sequencing (WES) in cases with ultrasound anomalies.
- Hereditary Cancer and Chronic Disease Panels: Genetic panels for hereditary cancer predispositions such as BRCA1/2 and Lynch syndrome, and for cardiovascular risk.